0001171843-16-013441.txt : 20161130
0001171843-16-013441.hdr.sgml : 20161130
20161130160139
ACCESSION NUMBER: 0001171843-16-013441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161128
FILED AS OF DATE: 20161130
DATE AS OF CHANGE: 20161130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001365216
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133929237
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 3019613400
MAIL ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenleaf Peter
CENTRAL INDEX KEY: 0001363683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33609
FILM NUMBER: 162025333
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
f4_greenleaf113016.xml
OWNERSHIP DOCUMENT
X0306
4
2016-11-28
0
0001365216
Sucampo Pharmaceuticals, Inc.
SCMP
0001363683
Greenleaf Peter
805 KING FARM BLVD, SUITE 550
ROCKVILLE
MD
20850
0
1
0
0
CEO
Common Stock, Class A
2016-11-28
4
M
0
117541
6.75
A
120054
D
Common Stock, Class A
2016-11-28
4
S
0
117541
16.91
D
2513
D
Common Stock, Class A
2016-11-29
4
M
0
82459
6.75
A
84972
D
Common Stock, Class A
2016-11-29
4
S
0
82459
16.75
D
2513
D
Employee Stock Option (right to buy)
6.75
2016-11-28
4
M
0
117541
0
D
2015-10-30
2024-09-11
Class A Common Stock
117541
1512459
D
Employee Stock Option (right to buy)
6.75
2016-11-29
4
M
0
82459
0
D
2015-10-30
2024-09-11
Class A Common Stock
82459
1430000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.35, inclusive. The reporting person will, upon request, provide any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.75 to $16.78, inclusive. The reporting person will, upon request, provide any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range.
/s/ Peter Greenleaf
2016-11-30